Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
70%??? I show 16%.
why we 70% down today???? thought it was a solid play!??
IMO in few days ))I'll buy below 0.02
The "E" is dropped.
i will ad more here for sure, after 12years of trading, i still sometimes don't get the market. We should have been at 0.7 and fall back today around 0.35 cents with this q. but hey, i will ad more here for next Q. glta
Bought 60k more. GLTA, Claude Alain (EOM)
no doubt - numbers will improve - I admit that quarterly caught me off guard - didnt see it coming thats for sure. but this stock is cyclical if nothing else - will see another appreciation come next quarterly
I will buy .03's in 7 weeks.
Shareholder equity is negative $.065/share when you back out intangible assets. And working capital is now negative after this disaster of a quarter. GLTY
Bought 5k more! GLTA, Claude Alain (EOM)
Been here for several months. I'm patient, lol.
Shhh, I'm still accumulating, lol ... .30 shareholder equity, not bad for a single-digit stock
Looking decent here. The Q should be read entirely before selling your shares. Still 16Mil in stockholder equity, which is around .30 per share equity. They have products and sales, but like many others they are hurt by the economy.
10Q link....pinksheets
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=7099913
KiK,
can you provide a link to this info? Thanks!
Shrinkage. Q2 loss $.08, revenues down over 50%
10-Q out this morning.
Got 26k more today at 0.09. GLTA, Claude Alain (EOM)
Still waiting. The late report kinda scared off a few, but numbers are numbers once they are published. Probably getting near, since we seem to be uptrending a bit this week.
What happened to the theory of buy on rumour sell on facts - I expected a lot more in the run up to the next figures - Just a little concerned as I would have thought there would be more than enough buyers who know someone who knew someone (if you know what I mean).
Yep, were looking good again. Shouldve grabbed more 7s, lol
indeed - if you look at the volume on the "negative" days its super low- got walked down, and substantial buyers are going to wait until the 10q hits so there was no pressure pushing it up. We saw though mid month Feb that it doesnt take much to clear a MM of his shares and that ask will fly to the sky with any good share volume.
this is like finding out christmas is going to be in January when Im all ready for it on Christmas Eve standing there with my cookies and milk in hand lol!
Yeah, there's always some panic when a company is late filing. Glad we got them out and it's especially nice to see the Accum/Dist still in an up-trend.
MMs dumped about 100k between last week and this week, so it's safe to say most of the selling was coming from them.
There were a few sellers when the Q was late, but seems most are holding now. Just waiting on the Q.
Got 20k more today at 0.09. Difficult to buy! GLTA, Claude Alain (EOM)
Hey all! was in costa rica for a while working and was out of touch with the rest of the world. thought we'd be at a buck by the time I got back - at least .50! guess we are still waiting on the quarterly filing- I just emailed their IR guy Richard Doyle - dont know if Ill hear back from him but if I do I will relay- Price action hasnt been all that great as far as us falling on low volume - nobody is really selling though -everyone knows great things are coming; just taking longer than we all thought.
Accumulation is still ramping up everyday on the charts - that is awesome as that is like a coiled spring when the filing is released we will have an incredibly strong base to launch up to where we should be. not enough volume to rely on many other charting metrix but other indicators like stochastics and money flow have bottomed since our initial runup to the usual quarterly release date and are now turning back north again - perhaps in expectation of the release coming soon again. nobody is going to sell into the crappy spreads they offer and especially when we all know the numbers are going to be great- you'd lose too much trying to chase
May have to move up on the .09. The Ask, .09, .102, .14.
I don't know what my average is since I've bought so many different times. I don't know about a 75 fill for 40K. That's amny shares.
Can't do AON via CREDIT SUISSE in Zurich (Switzerland), could do with my TD Ameritrade account, but no money left there!
Are you at 0.07 or higher? Don't think, I will be filled for the remainig 40k at 0.075.
GLTY, Claude Alain
This is a great one. Huge stockholder equity last Q, and a positive EPS of .02. They will file. Just a matter of when. Wasn't my fill yesterday. I'm sitting at AON.
Trying to buy 50k shares of AVMD. Got 10k yesterday at 0.075. Think you got the rest (500 shares).
I like to buy when there is an "E" at the end, but the company looks solid.
GLTA, Claude Alain
Got a couple on the .07 bid now.
I still can't get L2 on this.
I'm kinda thinking that. This bid is way more stacked than last week.
Someone get an early glimpse of the filing?
I need news!!!!!
This bid is stacked, one just UTd to .07, and 4 at .06. UT again, now .07/.095
Kuwlness, here with AVMD...
My sentiments are the same. AVMD will definitely be one to quietly accumulate. I think it's just a matter of time before they graduate to the next few levels. I will wait this out as long as it takes although I am expecting some financials to come out sometime this coming week to justify what I posted earlier below:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=46640557
v/r
Sterling
try this, it works fine
insert-text-here
Go to pinksheets.com. AVMDE working and real time - free. On the stocks quote page.
not working, tried it allready
what is the ask and bid now? level 2 not working on AVMD
I'll be a 5% shareholder if they keep giving me .06s, lol
I emailed them late last week. I received no reply. Hopefully you have better results.
lol, yeah, that makes two of us......I'm not just a shareholder, I'm a client!
yeah, the suspense is killing me too. I'm afraid that if they keep us, the shareholders, any longer some of us will end up as their clients... lol
I emailed IR today. will let you all know if/when i receive a reply.
Yes my friend it does!!!!
Followers
|
8
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1241
|
Created
|
10/23/09
|
Type
|
Free
|
Moderators |
http://www.amiaustralia.com.au/
http://www.avmd.com.au
Mission Statement
Advanced Medical Institute Inc. (collectively with its subsidiaries, “AVMD”) focuses on delivering safer, faster acting and lower dosage treatments to people suffering from impotence and premature ejaculation. Unlike many of our competitors, we treat the whole patient, individually and over the long term. AVMD’s strategy is to provide new methods of treatment and delivery systems that provide a practical non-invasive method of drug delivery to the body and by using existing drug products with known safety and efficacy. We market directly to the public. All medications are provided under individual prescriptions and our treatments are only available through our dedicated clinics under the supervision of trained medical personnel. At present our treatments are only available in Australia, New Zealand, China and the United Kingdom.
Company
AVMD, headquartered in Sydney, Australia, is a publicly held Nevada corporation that currently trades on the over-the-counter (bulletin board) market under the symbol AVMD.OB. AVMD operates primarily through its wholly-owned Australian subsidiary, AMI Australia. Please click here to access our current corporate structure chart. AVMD currently has approximately 53.5 million issued shares.Please click here to obtain further information on AVMD’s issued capital and a copy of AVMD’s financial reports.
Future Goals
One of AVMD’s goals is to extend the reach of our innovative treatment programs beyond Australia, New Zealand, China and the United Kingdom. We are exploring growth opportunities in Asia, Europe and the United States and on September 15, 2008, we announced expansion of our operations to the United Kingdom where we opened up our treatment centers, contracts with independent doctors and pharmacies and began airing infomercials throughout the country.
Based on publicly available Australian and Worldwide market information, the sexual dysfunction market share we have achieved in Australia and our analysis of the regulatory and market opportunities available in the United States and elsewhere, we are extremely excited by our prospects and our opportunities for growth in the coming years.
Latest 10Q Ending Sept 30, 2009
September 30, 2009 | June 30, 2009 | |||||||
ASSETS | ||||||||
CURRENT ASSETS | ||||||||
Cash & cash equivalents | $ | 344,270 | $ | 295,245 | ||||
Receivables, net | 27,632,227 | 24,021,361 | ||||||
Receivables due from related parties | 380,677 | 428,525 | ||||||
Inventory | 897,671 | 911,405 | ||||||
Other assets | 813,678 | 1,014,424 | ||||||
TOTAL CURRENT ASSETS | 30,068,523 | 26,670,960 | ||||||
NON-CURRENT ASSETS | ||||||||
Security deposits | 191,384 | 181,584 | ||||||
Property and equipment, net | 1,717,528 | 1,630,979 | ||||||
Assets related to discontinued operations | 301,542 | 289,977 | ||||||
Deferred tax assets | 264,479 | 678,270 | ||||||
Intangible assets, net | 19,538,754 | 18,327,078 | ||||||
TOTAL NON-CURRENT ASSETS | 22,013,687 | 21,107,888 | ||||||
TOTAL ASSETS | $ | 52,082,210 | $ | 47,778,848 | ||||
Three Month Periods Ended | ||||||||
September 30, 2009 | September 30, 2008 | |||||||
NET REVENUE | $ | 14,507,711 | $ | 15,944,448 | ||||
COST OF REVENUE | (3,291,231 | ) | (3,591,200 | ) | ||||
GROSS PROFIT | 11,216,480 | 12,353,248 | ||||||
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES | (9,774,975 | ) | (11,753,265 | ) | ||||
OPERATING INCOME | 1,441,505 | 599,983 | ||||||
OTHER INCOME AND (EXPENSE) | ||||||||
Bank interest | 1,736 | 34,610 | ||||||
Other income | - | 20,646 | ||||||
Interest expense | (154,022 | ) | (71,745 | ) | ||||
TOTAL OTHER INCOME (EXPENSE) | (152,286 | ) | (16,489 | ) | ||||
INCOME FROM CONTINUED OPERATIONS | 1,289,219 | 583,494 | ||||||
DISCONTINUED OPERATIONS | ||||||||
Loss from discontinued operations | (23,334 | ) | (95,001 | ) | ||||
Total loss from discontinued operations | (23,334 | ) | (95,001 | ) | ||||
INCOME BEFORE INCOME TAXES | 1,265,885 | 488,493 | ||||||
INCOME TAX EXPENSE | (449,333 | ) | (373,847 | ) | ||||
NET INCOME | 816,552 | 114,646 | ||||||
Other Comprehensive item - Foreign currency translation income (loss) | 1,179,276 | (4,854,822 | ) | |||||
Net Comprehensive Income (Loss) | $ | 1,995,828 | $ | (4,740,176 | ) | |||
Earnings per common share – continued operations | $ | 0.02 | $ | 0.00 | ||||
Earnings per common share – discontinued operations | $ | (0.00 | ) | $ | 0.00 | |||
Earnings per common share – basic & diluted | $ | 0.02 | $ | 0.00 | ||||
Weighted average number of shares, basic & diluted | 53,507,450 | 53,507,450 | |
Assets
AVMD’s wholly owned subsidiary, AMI Australia operates a centralized call center and twenty medical centers and sales offices throughout Australia, New Zealand, China and the United Kingdom.
AVMD’s core assets includes significant unique proprietary intellectual property developed during our subsidiaries’ business 16 years operating history. Our proprietary intellectual property includes:
Management
| Dr. Vaisman is the chief executive officer and a director of AVMD. Dr. Vaisman is a pioneer in the treatment of sexual dysfunction (impotence and premature ejaculation) in Australia. Since 2001, he has served as the Managing Director and Chief Executive Officer of AMI Australia, AVMD’s chief operating subsidiary. He is responsible for the overall management and strategic direction of AMI Australia's business operations. Dr. Vaisman was also the Founder and Director of On Clinic International in Australia. The holder of a Bachelor of Medicine, a Master of Gynaecology and a PhD in Medical Science, he has more than 35 years of experience and expertise in the field of sexual health care and was recently granted an innovation patent relating to the treatment of premature ejaculation by the Australian patent office. |
Tony Khan | Mr. Khan is AVMD’s Chief Operating Officer. Mr. Khan has served as Secretary and a Director of the Company since April 7, 2005. Mr. Khan also served as the chief operating officer of AMI Australia since July 1, 2005. From 2001 to July 1, 2005, Mr. Khan was the General Manager of AMI Australia, AVMD’s chief operating subsidiary. Previously, Khan founded, was the director and was the sole shareholder of Australian Momentum Health Pty Limited, a provider of impotency treatments in Australia and a predecessor of AMI Australia. Before founding Australian Momentum Health, he was Sales Manager and Operations Manager for On Clinic International Pty Limited. Mr. Khan holds a Masters degree in Commerce and Accounting and has been involved in the sexual dysfunction industry for over 10 years. |
Dilip Shrestha | Mr. Shrestha is the Chief Financial Officer of AVMD. Mr. Shrestha joined AMI Australia, AVMD’s chief operating subsidiary, in 2001 as a financial controller and was named Chief Financial Officer of AVMD on April 7, 2005. Prior to joining AMI Australia, he was a financial officer with Australian Momentum Health Pty Limited (a predecessor company of AMI Australia), a position he held from 1999 until 2001. He began his career as an operations and information technology manager with Kalinchowk Trading Company Ltd. Mr. Shrestha holds a Master’s degree in E-Commerce, a Graduate Diploma of Information Systems and E-Commerce and a Bachelor of Business Accounting. Mr. Shrestha is the co-developer of AVMD’s in-house proprietary enterprise software which is designed to oversee and manage AVMD’s business operations and which incorporates a customer management system that tracks customers from first contact to treatment program completion. |
|
SHARE STRUCTURE
As of November 23, 2009
Authorized Shares: 100,000,000
Outstanding Shares: 53,507,450
Float: 30,240,450
Name and Address of Beneficial Owner | Shares Beneficially Owned (1) | Percent of Class | ||||||
Jacov (Jack) Vaisman Unit 131 18-34 Waverley Street Bondi Junction NSW 2022 Australia | 10,250,000 | 19.16 | % | |||||
Forhad (Tony) Khan Suite 4, Level 1 26/3 Wolesly Grove Zetland NSW 2017 Australia | 250,000 | * | ||||||
Dilip Shrestha 18/30 Mary Street Lidcambe NSW 2141 Australia | 0 | * | ||||||
Anatoly Fanshil 22/2 Ocean Street Bondi Junction NSW 2026 Australia | 517,000 | * | ||||||
Spiro Baramilis 12 Merton Street Kogarah Bay NSW 2217 Australia | 0 | * | ||||||
Geissler Holdings Limited 1 Raffles Place #21-01 OUB Centre Singapore 048616 | 8,850,000 | (2) | 16.54 | % | ||||
RRD Investments Pty Limited 65 Prospect Road Summer Hills, NSW 2130 Australia | 3,400,000 | (3) | 6.35 | % | ||||
All Directors and Officers (5 people) | 11,017,000 | 20.59 | % |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |